The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Iodine In Bread Insufficient For Pregnant Women
Research shows that iodized salt found in bread is not enough to provide healthy levels of iodine for pregnant women and their unborn children.
East Asians Have Poorer Ability To Release Insulin, Study
Researchers have discovered that people of different ethnicity have differing abilities to release and react to insulin.
New Iron Catalyst Makes Hydrogenation Greener
A newly developed iron nanoparticle catalyst promises to drastically improve the efficiency of hydrogenation, making the process greener.
Intestine Bugs Could Be Key To Obesity-Cancer Link
New research shows that obesity is linked to an increase in the production of DNA-damaging acid that causes liver inflammation and cancer.
New Study Says Plant microRNA Cannot Enter Eater’s Bloodstream
New research refutes an earlier study that genetic elements from plants can make it into an eater's bloodstream.
Bizarre Sweet Potato-Shaped Spoon Worm Discovered In Japan
A peculiar sweet potato-like spoon worm, Arhynchite hayaoi, has been discovered in Japan.
EntreMed Files New Clinical Trial With CFDA For ENMD-2076
EntreMed, Inc. has submitted a new clinical trial application with the CFDA for its proprietary oncology drug candidate, ENMD-2076.
Australia’s CSIRO & DSTO To Partner On High-Tech Research
Australia's CSIRO and DSTO have signed a Strategic Relationship Agreement aimed at high-impact research priorities.
First iPSC Clinical Trial Endorsed By Japan Health Ministry Panel
A key panel of the Japanese Ministry of Health has given a conditional green light to clinical trials involving induced pluripotent stem cells.